Leadership Overview
MMS Holdings has 5 executives leading key functions including operations, financial strategy, information technology, and corporate leadership.
Focused on delivering science-first data services, MMS Holdings maintains a commitment to customer-driven outcomes and regulatory excellence for global sponsors through a dedicated, data-focused CRO model.
Focused on delivering science-first data services, MMS Holdings maintains a commitment to customer-driven outcomes and regulatory excellence for global sponsors through a dedicated, data-focused CRO model.
Leadership Roles at MMS Holdings
Evan Picard - Chief Financial Officer
Evan Picard, the Chief Financial Officer at MMS Holdings, manages the fiscal health and long-term financial strategy of the organization. Overseeing capital allocation and revenue growth initiatives, the Chief Financial Officer ensures that the firm maintains the stability required to support 950 colleagues worldwide. Picard directs financial planning and analysis to align with the company's mission of providing high-quality data services to global sponsors. By monitoring market trends and economic indicators, the Chief Financial Officer secures the resources necessary for continuous organic growth and infrastructure investment. Evan Picard collaborates with the executive team to evaluate the financial impact of new service offerings and regulatory submission projects. This leadership role involves maintaining rigorous fiscal discipline while fostering an environment where data-focused innovation thrives. Ultimately, the Chief Financial Officer provides the economic foundation that allows the firm to deliver consistent, high-value results to every sponsor partner.

Christopher Schoonmaker - Chief Operating Officer
Christopher Schoonmaker, the Chief Operating Officer at MMS Holdings, directs internal scaling and operational efficiency across the global organization. Overseeing the integration of data-focused CRO processes, the Chief Operating Officer ensures that internal workflows support the science-first approach required for complex regulatory submissions. Schoonmaker manages the alignment of cross-functional teams to maintain the 97 percent customer satisfaction rating while driving organic growth across international markets. By optimizing resource allocation and project management frameworks, the Chief Operating Officer enables colleagues to become deeply ingrained in sponsor projects. Christopher Schoonmaker monitors operational performance metrics to guarantee that every client receives the high level of care necessary for positive outcomes. Through rigorous process improvement and strategic oversight, the Chief Operating Officer sustains the dependable nature of the firm while expanding the capacity to handle diverse, changing sponsor needs in the competitive research and development landscape.
Micky Miranda - President
Micky Miranda, the President at MMS Holdings, drives the overarching corporate strategy and market expansion initiatives. Overseeing the execution of the firm's vision, the President ensures that the organization remains a leader in data-focused CRO services. Miranda directs the development of client relationships and monitors the quality of regulatory submission goals to uphold the company's 97 percent satisfaction rating. By fostering a culture of excellence and scientific rigor, the President guides the firm through complex market challenges and evolving sponsor requirements. Micky Miranda collaborates with the board and executive leadership to identify new opportunities for organic growth and service diversification. This leadership role involves maintaining the core values of dependability and customer-centricity while scaling operations to meet global demand. Through strategic decision-making and a focus on long-term success, the President ensures that the firm continues to provide exceptional value to sponsors in the research and development sector.
Yonghoon Jeong - President
Yonghoon Jeong, the President at MMS Holdings, manages the operational delivery and strategic partnerships within the organization. Overseeing the implementation of specialized data services, the President ensures that the firm meets the unique needs of sponsors through a science-first approach. Jeong directs the expansion of service capabilities and monitors the performance of project teams to guarantee consistent, high-quality outcomes. By focusing on the integration of regulatory expertise and data management, the President supports the firm's mission to provide comprehensive solutions for complex research projects. Yonghoon Jeong coordinates with other executives to align departmental goals with the company's broader growth objectives. This leadership role involves driving operational excellence and ensuring that the firm remains responsive to the changing landscape of the CRO industry. Through a commitment to process improvement and client success, the President strengthens the firm's market position and fosters a collaborative environment for all colleagues.
Michael Frakes - Chief Information Officer
Michael Frakes, the Chief Information Officer at MMS Holdings, architects the digital infrastructure and data security frameworks essential for a global CRO. Overseeing the technological systems that support complex regulatory submissions, the Chief Information Officer ensures that data integrity remains at the forefront of every project. Frakes directs the implementation of advanced analytics tools and secure platforms to facilitate seamless collaboration between the firm and its sponsors. By managing the digital transformation of internal processes, the Chief Information Officer drives efficiency and protects sensitive research information across all regional operations. Michael Frakes coordinates with the leadership team to integrate cutting-edge technology into the science-first service model. This role involves mitigating cyber risks and ensuring compliance with global data standards. Through the strategic deployment of information technology, the Chief Information Officer empowers the entire workforce to achieve superior outcomes for clients while maintaining the firm's reputation for reliability and precision.
Explore Leadership Teams in Business Services
Charles River has delivered solutions to accelerate the development of drugs, chemicals, and medical devices for the people and patients who need them. Our products and services support clients from basic research, discovery, and safety assessment, to manufacturing and commercialization. With this expansive end-to-end portfolio, global capacity, and proven scientific and regulatory advisors, our integrated approach enables maximum speed and confidence on the drive to market.
Company Leadership
AC

MH
Inotiv provides deep expertise and scientific capabilities across the discovery and continuum. We support our clients from the beginning of discovery, through investigational new drug (IND) and beyond, all with the aim of delivering a superlative experience. Combined with our long history and deep experience with supply of critical research models, including rodents, rabbits, and nonhuman primates, Inotiv is the right-sized CRO for your next project. With our dedication to attentive, decisive service, you can trust that every program is a priority. Benefit from our long and impeccable regulatory history, world-class team of scientists, and on-time quality data delivery.
Company Leadership RL
JK

ECRI is an independent, nonprofit organization dedicated to advancing the safety, quality, and cost-effectiveness of healthcare across all settings. With a strong focus on patient safety, evidence-based practices, and technology decision support, ECRI is widely recognized and trusted by healthcare leaders and government agencies around the world. For over fifty years, ECRI has earned its reputation through integrity, rigorous research, and a steadfast commitment to independence, supported by strict conflict-of-interest policies. It remains the only organization globally to perform independent evaluations of medical devices, with testing laboratories located in both North America and the Asia Pacific region. ECRI is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality and is a federally certified Patient Safety Organization by the U.S. Department of Health and Human Services. In 2020, the Institute for Safe Medication Practices (ISMP) officially became an affiliate of ECRI.
Company Leadership XW
JN
DK
Tigermed provides contract research organization services in China and internationally. It operates through Clinical Trial Solutions; and Clinical-Related and Laboratory Services. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. Tigermed was founded in 2004 and is located in Beijing, China.
Company Leadership
JM
BS
MW